✦ LIBER ✦

Radionuclide therapy with 111In-pentetreoide in five digestive metastatic neuroendocrine tumors (DNET)

✍ Scribed by Aparicio, Thomas; Sobhani, Iradj; Nguyen, Christian; Lebrahi, Rachida; Abramowitz, Laurent; Le Guludec, Dominique; Askienazy, S.; Mignon, Michel

Book ID: 122850721
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 163 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)81391-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tu1100 Organ Dysfunction After Delayed P

Tu1100 Organ Dysfunction After Delayed Peptide Receptor Radionuclide Therapy in Patients With Metastatic Neuroendocrine Tumors

✍ Singh, Maneesh H.; Soulen, Michael C.; Pryma, Daniel A.; Bennett, Bonita J.; Wil 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Somatostatin Receptor-Targeted Radionucl

Somatostatin Receptor-Targeted Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors

✍ Kwekkeboom, Dik J.; de Herder, Wouter W.; Krenning, Eric P. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Combined helical CT (hCT) and somatostat

Combined helical CT (hCT) and somatostatin receptor scintigraphy (SRS) improve the diagnosis in patients with digestive neuroendocrine tumors (dNET)

✍ Moretti, Alessandra; Panzuto, Francesco; Bezzi, Mario; Gualdi, Gianfranco; Angel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Could somatostatin receptor subtypes (ss

Could somatostatin receptor subtypes (sst) expression be considered as positive prognostic factor in patients with digestive neuroendocrine tumors (dNETs)?

✍ Corleto, Vito D.; Ciardi, Sara; De Luca, Ottavia; Moretti, Alessandra; Panzuto, 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 369 KB

The palliative role of 131I-MIBG and 111

The palliative role of 131I-MIBG and 111In-octreotide therapy in patients with metastatic progressive neuroendocrine neoplasms

✍ Janice L. Pasieka; Alexander J.B. McEwan; Otto Rorstad 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 259 KB

Survival and Response After Peptide Rece

Survival and Response After Peptide Receptor Radionuclide Therapy With [90Y-DOTA0,Tyr3]Octreotide in Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors

✍ Roelf Valkema; Stanislas Pauwels; Larry K. Kvols; Raffaella Barone; Francois Jam 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 288 KB